发明授权
- 专利标题: Genetically modified mice and engraftment
- 专利标题(中): 转基因小鼠和植入物
-
申请号: US12897517申请日: 2010-10-04
-
公开(公告)号: US08541646B2公开(公告)日: 2013-09-24
- 发明人: Sean Stevens , Andrew J. Murphy , Richard Flavell , Elizabeth Eynon , Jorge Galan , Tim Willinger , Markus Manz , Anthony Rongvaux , George D. Yancopoulos
- 申请人: Sean Stevens , Andrew J. Murphy , Richard Flavell , Elizabeth Eynon , Jorge Galan , Tim Willinger , Markus Manz , Anthony Rongvaux , George D. Yancopoulos
- 申请人地址: US NY Tarrytown US CT New Haven CH Bellinzona
- 专利权人: Regeneron Pharmaceuticals, Inc.,Yale University,Institute for Research in Biomedicine
- 当前专利权人: Regeneron Pharmaceuticals, Inc.,Yale University,Institute for Research in Biomedicine
- 当前专利权人地址: US NY Tarrytown US CT New Haven CH Bellinzona
- 代理商 Tor Smeland; Margarita Zippin; Elizabeth A. Alcamo
- 主分类号: A01K67/027
- IPC分类号: A01K67/027 ; G01N33/00
摘要:
A mouse with a humanization of the mIL-3 gene and the mGM-CSF gene, a knockout of a mRAG gene, and a knockout of a mIl2rg subunit gene; and optionally a humanization of the TPO gene is described. A RAG/Il2rg KO/hTPO knock-in mouse is described. A mouse engrafted with human hematopoietic stem cells (HSCs) that maintains a human immune cell (HIC) population derived from the HSCs and that is infectable by a human pathogen, e.g., S. typhi or M. tuberculosis is described. A mouse that models a human pathogen infection that is poorly modeled in mice is described, e.g., a mouse that models a human mycobacterial infection, wherein the mouse develops one or more granulomas comprising human immune cells. A mouse that comprises a human hematopoietic malignancy that originates from an early human hematopoietic cells is described, e.g., a myeloid leukemia or a myeloproliferative neoplasia.
公开/授权文献
- US20110200982A1 GENETICALLY MODIFIED MICE AND ENGRAFTMENT 公开/授权日:2011-08-18
信息查询